# Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass.

Study · id `cardio:ct-nct01802619` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01802619](<https://clinicaltrials.gov/study/NCT01802619>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01802619

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 217 participants.

## Technical summary

Registry record NCT01802619. Randomized; double masking; primary purpose prevention. Start 2013-08 (actual); primary completion 2015-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 1/2
- Enrolled: 217 participants (enrolled count; ClinicalTrials.gov record NCT01802619, source copy `cardio:ctgov-nct01802619-2018-02-13`, retrieved 2026-10-26)
- Started: 2013-08 (actual) (ClinicalTrials.gov record NCT01802619, source copy `cardio:ctgov-nct01802619-2018-02-13`, retrieved 2026-10-26)
- Primary completion: 2015-06 (actual) (ClinicalTrials.gov record NCT01802619, source copy `cardio:ctgov-nct01802619-2018-02-13`, retrieved 2026-10-26)
- Completion: 2016-06 (actual) (ClinicalTrials.gov record NCT01802619, source copy `cardio:ctgov-nct01802619-2018-02-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01802619, source copy `cardio:ctgov-nct01802619-2018-02-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01802619-2018-02-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass.
- Condition: Heart Valve Diseases
- Condition: Heart; Complications, Valve, Prosthesis
- Condition: Cardiac Valve Replacement Complication
- Intervention (Other): inhaled nitric oxide
- Intervention (Other): inhaled Nitrogen
- Lead sponsor: Xijing Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Xijing Hospital (`cardio:org-xijing-hospital`)

## Provenance

Content hash: 20cb812f56b7f368e49aacaec9e25501fde23098f3ff3459bf03b69f1db5a89d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
